Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Rebound Therapeutics

Rebound Therapeutics
2015 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Developer of medical devices designed to offer medical devices for minimally invasive surgery (MIS) procedures. The company's medical devices include MIS access and therapeutic devices that offer state-of-the-art imaging and illumination technologies and are used for a variety of surgical procedures including neurosurgery, spine and orthopedic surgery, thoracic and general abdominal surgery, enabling physicians to carry out MIS procedures for the displacement of the large, complex and capital equipment in operating rooms

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Biotechnology
Therapeutic Devices
Parent Company
Primary Office
  • 13844 Alton Parkway
  • Suite 120
  • Irvine, CA 92618
  • United States

+1 (949) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Rebound Therapeutics’s full profile, request a free trial.

Rebound Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Sep-2019 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 25-Jul-2017 000.00 000.00 000.00 Completed Stealth
1. Angel (individual) 29-Dec-2015 $3.76M $3.76M 00.000 Completed Stealth
To view this company’s complete deal history including valuation and funding, request access »

Rebound Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 000
To view this company’s complete Cap Table, request access »

Rebound Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
HBM-MedFocus Fund Lender/Debt Provider Minority 000 0000 000000 0
The Invus Group PE/Buyout Minority 000 0000 000000 0
Wexford Capital Hedge Fund Minority 000 0000 000000 0

Rebound Therapeutics Executive Team (7)

Name Title Board
Seat
Contact
Info
Jeffrey Valko Chief Executive Officer, President & Board Member
Pete Davis Chief Technology Officer
Ross Tsukashima Chief Scientific Officer
Tracy Pearson Executive Officer, Secretary & Treasurer
Michael Henson Executive Officer & Board Member
You’re viewing 5 of 7 executives. Get the full list »

Rebound Therapeutics Board Members (2)

Name Representing Role Since Contact
Info
Jeffrey Valko Rebound Therapeutics Chief Executive Officer, President & Board Member 000 0000
Michael Henson Rebound Therapeutics Executive Officer & Board Member 000 0000